Shiga, Japan Clinical Trials
A listing of Shiga, Japan clinical trials actively recruiting patients volunteers.
This is a phase 1, open-label, multicenter, dose escalation study to evaluate the safety and tolerability of bosutinib to determine the maximum tolerated dose(MTD) and a recommended phase 2 dose (RP2D) of bosutinib for treatment of ALS patients. Also, efficacy will be evaluated exploratory.
- 0 views
- 19 Feb, 2021
- +3 other locations